Schwartz Aharon

CIK 00016251843 companiesMODII'N

SEC Profile

Transactions

Companies

Filings

CIK

0001625184

Recent Transactions

20 trades

Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2025-09-03+15,000→ 15,000 total
Award
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2025-09-03+7,500→ 7,500 total
Purchase
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2025-06-10$1.60/sh+129,000→ 303,000 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Option (Right to Buy)
2023-09-29+61,676→ 61,676 total
Purchase
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2023-01-03$1.42/sh+110,000→ 174,000 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2022-09-07+50,000→ 50,000 total
Purchase
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2020-04-07$2.43/sh+64,000→ 64,000 total
Disposition to Issuer
Foamix Pharmaceuticals Ltd.
Options
2020-03-09−24,000→ 0 total
Disposition to Issuer
Foamix Pharmaceuticals Ltd.
Ordinary Shares
2020-03-09−112,200→ 0 total
Disposition to Issuer
Foamix Pharmaceuticals Ltd.
Options
2020-03-09−24,883→ 0 total
Disposition to Issuer
Foamix Pharmaceuticals Ltd.
Options
2020-03-09−21,435→ 0 total
Disposition to Issuer
Foamix Pharmaceuticals Ltd.
Options
2020-03-09−49,412→ 0 total
Disposition to Issuer
Foamix Pharmaceuticals Ltd.
Options
2020-03-09−38,156→ 0 total
Award
Foamix Pharmaceuticals Ltd.
Options
2020-02-27+38,156→ 38,156 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2020-01-20+40,000→ 40,000 total
Award
Foamix Pharmaceuticals Ltd.
Options
2019-05-16+49,412→ 49,412 total
Purchase
Foamix Pharmaceuticals Ltd.
Ordinary Shares
2018-11-28$3.88/sh+12,200→ 112,200 total
Purchase
Foamix Pharmaceuticals Ltd.
Ordinary Shares
2018-11-27$3.92/sh+50,000→ 100,000 total
Purchase
Foamix Pharmaceuticals Ltd.
Ordinary Shares
2018-11-26$3.89/sh+50,000→ 50,000 total
Award
Foamix Pharmaceuticals Ltd.
Options
2018-05-08+24,883→ 24,883 total

Companies

Recent Filings

Address

BIOLINERX LTD. 2 HAMA'AYAN STREET

MODII'N, 7177871

View on SEC.gov